Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myrtol for prevention of late radiotherapy complications in sinonasal tumors
ChiCTR-TRC-12002800Phase 4Completed
- Sponsor
- Xijing Hospital
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of myrtol in Nasal neoplasm (2 arms), sponsored by Xijing Hospital. Primary endpoint: Sinusitis. Started Oct 2012; status: completed.
02
Drugs
myrtol
03
Conditions
Nasal neoplasm
Beyond the preview
Go deeper on ChiCTR-TRC-12002800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002800.